Analysts Set Omega Healthcare Investors, Inc. (NYSE:OHI) Target Price at $39.70

Omega Healthcare Investors, Inc. (NYSE:OHI) has earned an average recommendation of “Hold” from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $40.00.

A number of analysts have commented on OHI shares. Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $40.01 on Friday. Omega Healthcare Investors has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a market capitalization of $10.80 billion, a PE ratio of 29.42, a PEG ratio of 1.25 and a beta of 0.99. The business has a fifty day moving average price of $40.65 and a 200-day moving average price of $36.59. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.70%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Activity at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth about $26,000. UMB Bank n.a. grew its position in Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 516 shares in the last quarter. True Wealth Design LLC bought a new stake in Omega Healthcare Investors during the third quarter worth approximately $31,000. Dunhill Financial LLC purchased a new stake in Omega Healthcare Investors during the third quarter valued at approximately $31,000. Finally, DiNuzzo Private Wealth Inc. bought a new stake in shares of Omega Healthcare Investors in the 3rd quarter valued at approximately $33,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.